CONTINUOUS ARTERIOVENOUS HEMODIAFILTRATION IN THE ACUTE TREATMENT OF HYPERAMMONAEMIA DUE TO ORNITHINE TRANSCARBAMYLASE DEFICIENCY

Renal Failure ◽  
2000 ◽  
Vol 22 (6) ◽  
pp. 823-836 ◽  
Author(s):  
Chen-Yin Chen ◽  
Yung-Chang Chen ◽  
Ji-Tseng Fang ◽  
Chiu-Ching Huang
Keyword(s):  
Acute Treatment ◽  
Ornithine Transcarbamylase ◽  
Ornithine Transcarbamylase Deficiency

scholarly journals Ornithine transcarbamylase deficiency: A possible risk factor for thrombosis

2009 ◽  
Vol 53 (1) ◽  
pp. 100-102 ◽  
Author(s):  
Lakshmi Venkateswaran ◽  
Fernando Scaglia ◽  
Valerie McLin ◽  
Paula Hertel ◽  
Oleg A. Shchelochkov ◽  
...  
Keyword(s):  
Risk Factor ◽  
Ornithine Transcarbamylase ◽  
Ornithine Transcarbamylase Deficiency

scholarly journals Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency

2019 ◽  
Vol 2019 ◽  
pp. 1-6 ◽  
Author(s):  
Lin Cheng ◽  
Yajuan Liu ◽  
Wenjing Wang ◽  
J. L. Merritt ◽  
Matthew Yeh
Keyword(s):  
Liver Damage ◽  
English Language ◽  
Scientific Literature ◽  
Hepatocellular Adenoma ◽  
Ornithine Transcarbamylase ◽  
Ornithine Transcarbamylase Deficiency ◽  
Otc Deficiency

Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific literature.

Sign in / Sign up

Export Citation Format

Share Document